VCBeat Health Contact Us
Home First Wave Announces Global Exclusive License Agreement with Sanofi for Capeserod

First Wave Announces Global Exclusive License Agreement with Sanofi for Capeserod

Sep 14, 2023 18:11 CST Updated 18:11
Sanofi

Pharmaceutical R&D Developer

First Wave BioPharma

Biological New Drug Developer

First Wave BioPharma Announces Agreement with Sanofi to License Capeserod for GI Indications